Xi'an Manareco New Materials

Xi'an Manareco New Materials specializes in the R&D and manufacturing of organic chemicals, including pharmaceutical intermediates and excipients. The company serves as a key supplier to major international pharmaceutical companies, providing critical raw materials for APIs and formulations. It does not develop its own drug pipeline. In addition to healthcare/pharma applications, it also produces advanced materials for display technologies such as OLEDs and liquid crystals. The company operates multiple production sites with cGMP capabilities, including a new site that began operation in 2022 with four cGMP workshops under construction. It has been publicly listed on the Shanghai Stock Exchange since 2020 under the symbol "688550".